Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,858.00p on 13-01-2026 at 19:40:06
Change -19.00p -1.01%
Buy 1,853.50p
Sell 1,853.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 805.00 at 1,858.00p
Day's Volume: 5,789,190
Last Close: 1,858.00p
Open: 1,868.50p
ISIN: GB00BN7SWP63
Day's Range 1,833.00p - 1,874.00p
52wk Range: 1,242.50p - 1,909.50p
Market Capitalisation: £74.95b
VWAP: 1,858.79347p
Shares in Issue: 4.03b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 805 1,858.00p SI Trade
Negotiated Trade
 17:08:43 - 13-Jan-26
Buy* 3,624 1,858.00p SI Trade
Negotiated Trade
 17:08:42 - 13-Jan-26
Buy* 170 1,858.00p SI Trade
Negotiated Trade
 17:08:42 - 13-Jan-26
Buy* 88,725 1,858.00p SI Trade
Negotiated Trade
 17:08:41 - 13-Jan-26
Buy* 3,675 1,858.00p SI Trade
Negotiated Trade
 17:08:41 - 13-Jan-26
Buy* 5,402 1,858.00p SI Trade
Negotiated Trade
 17:08:27 - 13-Jan-26
Buy* 1,054 1,858.00p SI Trade
Negotiated Trade
 17:08:27 - 13-Jan-26
Buy* 47,338 1,858.00p SI Trade
Negotiated Trade
 17:08:27 - 13-Jan-26
Buy* 19,398 1,858.00p SI Trade
Negotiated Trade
 17:08:24 - 13-Jan-26
Buy* 7,081 1,858.00p SI Trade
Negotiated Trade
 17:08:24 - 13-Jan-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Jan 2026 (Tue) 1,868.50 1,874.00 1,833.00 1,858.00 5,789,190
12th Jan 2026 (Mon) 1,879.50 1,902.00 1,866.00 1,877.00 5,647,857
9th Jan 2026 (Fri) 1,875.00 1,896.00 1,871.00 1,886.00 6,348,596
8th Jan 2026 (Thu) 1,891.50 1,908.50 1,880.00 1,891.00 6,026,419
7th Jan 2026 (Wed) 1,902.00 1,909.50 1,869.50 1,901.50 7,532,634
6th Jan 2026 (Tue) 1,818.00 1,905.50 1,817.50 1,899.50 11,458,875
5th Jan 2026 (Mon) 1,846.00 1,847.00 1,800.00 1,820.50 5,344,789
2nd Jan 2026 (Fri) 1,828.00 1,849.00 1,821.00 1,831.50 5,188,093
1st Jan 2026 (Thu) 1,824.50 1,824.50 1,824.50 1,824.50 0
31st Dec 2025 (Wed) 1,833.50 1,835.00 1,824.50 1,824.50 2,468,218
30th Dec 2025 (Tue) 1,815.00 1,835.00 1,812.50 1,830.50 3,231,417
29th Dec 2025 (Mon) 1,815.50 1,823.50 1,810.50 1,823.00 3,647,051
26th Dec 2025 (Fri) 1,805.50 1,805.50 1,805.50 1,805.50 0
25th Dec 2025 (Thu) 1,805.50 1,805.50 1,805.50 1,805.50 0
24th Dec 2025 (Wed) 1,803.50 1,806.00 1,793.00 1,805.50 1,461,989
23rd Dec 2025 (Tue) 1,809.50 1,823.00 1,805.00 1,814.50 5,326,874
22nd Dec 2025 (Mon) 1,808.50 1,820.50 1,803.50 1,810.00 6,966,644
19th Dec 2025 (Fri) 1,805.00 1,822.00 1,798.50 1,822.00 20,121,835
18th Dec 2025 (Thu) 1,817.50 1,820.00 1,797.50 1,812.50 7,352,624
17th Dec 2025 (Wed) 1,826.00 1,850.50 1,823.50 1,833.50 10,914,252
16th Dec 2025 (Tue) 1,844.50 1,850.00 1,816.00 1,819.50 7,636,767
15th Dec 2025 (Mon) 1,819.00 1,838.50 1,810.00 1,833.50 10,789,160
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
13th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
7th Jan 2026 7:05 am RNS EC approval of Shingrix PFS
7th Jan 2026 7:00 am RNS Positive phase 3 data for GSK's bepirovirsen
6th Jan 2026 7:00 am RNS Exdensur approved in Japan
5th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
5th Jan 2026 3:00 pm RNS Total Voting Rights
5th Jan 2026 7:00 am RNS Nucala for adults with COPD approved in China
22nd Dec 2025 3:30 pm RNS Director/PDMR Shareholding
22nd Dec 2025 3:30 pm RNS Director/PDMR Shareholding
22nd Dec 2025 7:00 am RNS GSK to lower drug prices and expand access in US
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON BROKER RATINGS: Berenberg raises Vodafone; Barclays cuts Hikma

7th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET OPEN: FTSE 100 retreats from high as oil firms fall

7th Jan 2026 09:09

(Alliance News) - Stock prices in London opened lower on Wednesday, as the FTSE 100 retreated from a record high, as oil firms BP and Shell weighed on the blue-chip index. Read More

GSK reports positive data, secures Shingrix presentation approval

7th Jan 2026 08:41

(Alliance News) - GSK PLC on Wednesday reported positive developments with its shingles vaccine and its potential treatment for chronic hepatitis B, as it secured a presentation approval and announced positive data. Read More

LONDON MARKET CLOSE: Next impresses as FTSE 100 rockets to fresh high

6th Jan 2026 17:04

(Alliance News) - Blue chips continued their strong start to the year on Tuesday with the FTSE 100 hitting a new record led by gains in retailer Next and drug stocks, GSK and AstraZeneca. Read More

GSK's Exdensur backed in Japan as asthma and rhinosinusitis treatment

6th Jan 2026 09:02

(Alliance News) - GSK PLC on Tuesday said depemokimab, sold under the brand name Exdensur, has been approved by Japan's Ministry of Health, Labour and Welfare for severe asthma and chronic rhinosinusitis with nasal polyps. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,137.35
Change-3.35

Login to your account

Forgot Password?

Not Registered